Newsroom

Newsroom

Characterizing CD39 and CD73 cell subtypes in the tumor microenvironment using MultiOmyx immunofluorescence assay

Literature
Read More

Comprehensive analysis of natural killer cell-associated markers using MultiOmyx immunofluorescence assay

Literature
Read More

Single-cell immunoprofiling and spatial analysis of hormone receptor subtypes in HER2+ and HER2low breast tumors using multiplexed immunofluorescence

Literature
Read More

ctDNA dynamics in early stage node negative non-small cell lung cancers

Literature
Read More

Evaluation of a tumor informed MRD assay with contrived breast cancer samples

Literature
Read More

Landscape of known and novel myeloid neoplasia fusions identified by a multimodal comprehensive genomic profiling test in 789 patients

Literature
Read More

NeoGenomics to Announce First Quarter 2023 Financial Results

Press Release
Read More

Single-tube NGS profiling allows identification of molecular signature in ALL patients

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients